CNBC: Moderna announces single shot booster for the coronavirus and the common flu

33

Moderna announced this week that they are working on a two-in-one vaccine that would combine their covid vaccine with a flu shot currently under development. The new shot, called mRNA-1073, would hopefully increase convenience for individuals who plan on receiving a booster shot. The company hopes that the vaccine will be updated and administered yearly, much as the flu vaccine is today. Clinical testing is expected to begin in the next 6 to 12 months. Following the news, the cost of Moderna’s shares increased by more than 5%. The company also has plans to produce a pediatric vaccine that aims to protect against respiratory syncytial virus and human metapneumovirus. Read more about the vaccine here and more about the market response here. 



Comments are closed.

Skip to toolbar